A New Challenge and Responsibility for the Future
NANO Holdings embarked on a new journey on December 11, 2025. The environment surrounding unlisted biotech ventures remains challenging. However, we view this adversity as an opportunity for growth, building a business model that not only strengthens our proprietary pipeline but also nurtures innovative technologies from numerous companies and returns them to society.
Evolving into a Healthcare Conglomerate
We aim to function not merely as an investment company but as a platform for value creation at the core of the healthcare industry. Diverse companies will pass through us, grow, and contribute to society. Our mission is to build a system that generates meaningful value for the world.
Maximizing Shareholder Value and Driving Sustainable Growth
Going forward, we will focus on two key priorities:
- Expanding option value and revenue growth through strategic acquisitions
- Maximizing shareholder returns by optimizing equity value
Through this strategy, we will deliver long-term, sustainable value to our shareholders and shape the future of healthcare.
Creating the Future Together
We will continue to embrace challenges, drive transformation, and evolve into a corporate group that the world truly needs. With your support and trust, we are committed to achieving this vision.
